Last update 20 Oct 2025

Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome Eye Drops(Hangzhou Protobiology Technology)

Overview

Basic Info

Drug Type
Exosomes
Synonyms
PSC-MSC-Exo Eye Drops(Hangzhou Protobiology Technology)
Target-
Action-
Mechanism-
Therapeutic Areas
Eye Diseases
Active Indication-
Inactive Indication
BlepharospasmDry Eye Syndromes
Originator Organization
Hangzhou Protobiology Technology Co., Ltd.Hangzhou Protobiology Technology Co., Ltd.
Active Organization-
Inactive Organization
Hangzhou Protobiology Technology Co., Ltd.Hangzhou Protobiology Technology Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome Eye Drops(Hangzhou Protobiology Technology)
NCT05738629
/ Unknown statusPhase 1/2IIT
A Clinical Study of the Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm
100 Clinical Results associated with Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome Eye Drops(Hangzhou Protobiology Technology)
Login to view more data
100 Translational Medicine associated with Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome Eye Drops(Hangzhou Protobiology Technology)
Login to view more data
100 Patents (Medical) associated with Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome Eye Drops(Hangzhou Protobiology Technology)
Login to view more data
100 Deals associated with Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome Eye Drops(Hangzhou Protobiology Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
BlepharospasmPhase 2
China
Hangzhou Protobiology Technology Co., Ltd.Hangzhou Protobiology Technology Co., Ltd.
01 Mar 2023
Dry Eye SyndromesPhase 2
China
Hangzhou Protobiology Technology Co., Ltd.Hangzhou Protobiology Technology Co., Ltd.
01 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free